Eurofins Scientific SE ERF

Morningstar Rating
€55.00 −0.50 (0.90%)
View Full Chart

Company Report

Eurofins Returning to Growth After a Challenging 2023

Luxembourg-based Eurofins is one of the world’s largest testing, inspection, and certification, or TIC companies, with a focus on sample-based bioanalytical tests. Eurofins has global leadership positions in food and feed, environmental, and pharmaceutical testing. By investing in internal expansion as well as external acquisitions, it builds out decentralized “hub-and-spoke” lab networks that offer comprehensive testing solutions and short turnaround times. Customer relationships are often long-lasting, especially with large multinational customers who require a lab partner with a strong reputation and track record, broad testing capabilities that are accredited across many territories, and innovative testing solutions.

Price vs Fair Value

ERF is trading at a 234% premium.
Price
€55.00
Fair Value
€99.00
Uncertainty
Very High
1-Star Price
€653.00
5-Star Price
€99.00
Economic Moat
Sdrjhdk
Capital Allocation
Kmtmspwd

Bulls Say, Bears Say

Bulls

Eurofins has consistently delivered organic growth greater than global economic growth, a sign of consistent share gains despite high market competition and fragmentation.

Bears

Operating margins have fallen recently due to wage inflation in Europe, and it remains to be seen to what extent Eurofins can increase pricing to improve margins.

News

Trading Information

Previous Close Price
€55.50
Day Range
€54.5055.90
52-Week Range
€39.4762.10
Bid/Ask
€54.44 / €55.06
Market Cap
€10.41 Bil
Volume/Avg
370,851 / 363,324

Key Statistics

Price/Earnings (Normalized)
17.10
Price/Sales
1.61
Dividend Yield (Trailing)
0.91%
Dividend Yield (Forward)
0.91%
Total Yield
1.38%

Company Profile

Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its areas of business activity are food, feed, and environmental testing ("Life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
62,000

Competitors

Valuation

Metric
ERF
ITRK
BVI
Price/Earnings (Normalized)
17.1021.0122.08
Price/Book Value
2.486.257.98
Price/Sales
1.612.462.22
Price/Cash Flow
9.7414.9415.25
Price/Earnings
ERF
ITRK
BVI

Financial Strength

Metric
ERF
ITRK
BVI
Quick Ratio
1.201.251.31
Current Ratio
1.421.271.33
Interest Coverage
4.3010.298.83
Quick Ratio
ERF
ITRK
BVI

Profitability

Metric
ERF
ITRK
BVI
Return on Assets (Normalized)
5.87%10.62%8.39%
Return on Equity (Normalized)
15.26%29.30%33.46%
Return on Invested Capital (Normalized)
8.23%15.57%13.18%
Return on Assets
ERF
ITRK
BVI

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
GfvxxycgwGmz$228.7 Bil
Danaher Corp
DHR
DghwcmhgjxVtjjj$195.0 Bil
IQVIA Holdings Inc
IQV
GqkyrphcGgwbsmb$41.9 Bil
Agilent Technologies Inc
A
VwppqmpctrDydr$41.7 Bil
IDEXX Laboratories Inc
IDXX
PrbjwbhmzxYjdb$39.3 Bil
Mettler-Toledo International Inc
MTD
FdxnkwlkdZxlmgvf$30.8 Bil
Icon PLC
ICLR
RmvxmkqTprclt$24.3 Bil
Illumina Inc
ILMN
NyxlrpzzJwqzhl$22.5 Bil
Waters Corp
WAT
TclqbgclkVdjp$20.9 Bil
Labcorp Holdings Inc
LH
VtgxwqjsdxYrpljk$18.1 Bil

Sponsor Center